XRAY
DENTSPLY SIRONA Inc.
Healthcare · Medical - Instruments & Supplies
Deeply Undervalued·Quality 65·RSI 45·DCF -223%·Conviction 75
Investment Thesis — DENTSPLY SIRONA Inc.
The market overreacts to recent losses and negative EPS, missing that DENTSPLY SIRONA's core dental business remains cash generative and is positioned for margin recovery as restructuring plays out. The current price implies permanent impairment, but normalized earnings power is understated given the company's entrenched position in dental equipment and consumables.
Catalysts
- Successful execution of restructuring plan
- Stabilization or growth in dental procedure volumes
- Confirmation of dividend sustainability in upcoming quarters
Risk Factors
- Restructuring execution failure
- Further decline in dental market demand
- Dividend cut triggering investor exodus
Key Debates
Revenue Growth Turns Positive 1% by H2 2024
Fwd P/E Rerates to 10x by Q4 on Cost Cuts
Analyst PT 13.33 Achieved by Q3 on Turnaround